In this model, T3 completely prevented the development of hepatic steatosis by increasing fatty acid mitochondrial and peroxisomal β-oxidation and decreasing the expression of liver-type fatty acid-binding protein (L-FABP) (10). Here, FABP1 is linked to fatty liver disease.